OppenheimerFunds, Inc. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
OppenheimerFunds, Inc. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2019$140,456,000
+75.4%
892,749
+10.6%
0.18%
+53.5%
Q4 2018$80,086,000
-30.6%
807,329
+2.1%
0.11%
-14.9%
Q3 2018$115,478,000
-7.3%
790,936
-0.4%
0.13%
-10.1%
Q2 2018$124,638,000
-5.3%
794,126
+3.0%
0.15%
-9.1%
Q1 2018$131,667,000
-23.1%
771,110
-19.8%
0.16%
-20.8%
Q4 2017$171,275,000
+28.8%
961,682
-0.7%
0.21%
+27.0%
Q3 2017$132,977,000
+29.5%
968,161
-0.9%
0.16%
+28.3%
Q2 2017$102,658,000
+16.1%
977,231
+0.5%
0.13%
+18.7%
Q1 2017$88,387,000
+47.5%
972,352
+0.1%
0.11%
+40.8%
Q4 2016$59,940,000
+12.2%
971,471
+23.3%
0.08%
+13.4%
Q3 2016$53,418,000
-8.8%
788,099
-41.7%
0.07%
-13.0%
Q2 2016$58,543,000
+5.1%
1,352,334
+3.1%
0.08%
+4.1%
Q1 2016$55,721,000
-67.0%
1,311,084
-50.2%
0.07%
-31.5%
Q4 2015$169,068,000
+75.3%
2,632,648
+133.5%
0.11%
-16.9%
Q3 2015$96,456,000
-16.8%
1,127,484
+63.8%
0.13%
-2.3%
Q2 2015$115,897,000
+36.1%
688,350
-2.4%
0.13%
+40.0%
Q1 2015$85,184,000
+23.4%
705,340
-6.3%
0.10%
+23.4%
Q4 2014$69,025,000752,5600.08%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 82,500$5,090,0004.20%
RTW INVESTMENTS, LP 122,576$7,563,0002.85%
Eventide Asset Management 587,677$36,260,0002.36%
First Light Asset Management, LLC 71,246$4,396,0001.93%
ARK Investment Management 75,645$4,667,0001.70%
Taylor Wealth Management Partners 39,118$2,414,0001.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 302,027$18,635,0000.77%
ARMISTICE CAPITAL, LLC 40,000$2,468,0000.58%
Artal Group S.A. 422,536$26,070,0000.58%
TURNER INVESTMENTS LLC 21,020$1,297,0000.52%
View complete list of BLUEBIRD BIO INC shareholders